JAGUAR HEALTH, INC. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- JAGUAR HEALTH, INC. stock issued during period, shares, new issues for the quarter ending 2018-06-30 was 0.00 shares.
- JAGUAR HEALTH, INC. stock issued during period, shares, new issues for the quarter ending 2018-03-31 was 6.00M shares.
- JAGUAR HEALTH, INC. stock issued during period, shares, new issues for the quarter ending 2016-09-30 was 1.00M shares.
- JAGUAR HEALTH, INC. stock issued during period, shares, new issues for fiscal 2017 was 6.00M shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | |
| 2018-03-31 | 6.00M shares 10-Q · filed 2018-05-15 | |
| 2017-12-31 | 6.00M shares 10-K · filed 2018-04-09 | |
| 2016-09-30 | 1.00M shares 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |